Host: |
Rabbit |
Applications: |
WB/IHC/IF/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Actin-like protein 6A (201-250 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000IHC 1:100-1:300IF 1:200-1:1000ELISA 1:10000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
ACTL6A |
Gene ID: |
86 |
Uniprot ID: |
ACL6A_HUMAN |
Immunogen Region: |
201-250 aa |
Specificity: |
BAF53 Polyclonal Antibody detects endogenous levels of BAF53 protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human ACTL6A at the amino acid range 201-250 |
Protein Name | Actin-Like Protein 6a53 Kda Brg1-Associated Factor AActin-Related Protein Baf53aArpnbetaBrg1-Associated Factor 53aBaf53aIno80 Complex Subunit K |
Database Links | Reactome: R-HSA-3214847Reactome: R-HSA-3214858Reactome: R-HSA-5689603Reactome: R-HSA-5696394Reactome: R-HSA-8939243 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Actin-Like Protein 6a antibodyAnti-53 Kda Brg1-Associated Factor A antibodyAnti-Actin-Related Protein Baf53a antibodyAnti-Arpnbeta antibodyAnti-Brg1-Associated Factor 53a antibodyAnti-Baf53a antibodyAnti-Ino80 Complex Subunit K antibodyAnti-ACTL6A antibodyAnti-BAF53 antibodyAnti-BAF53A antibodyAnti-INO80K antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance